Lv56
1124 积分 2024-09-13 加入
Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trials
3天前
已完结
Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps
3天前
已完结
Global Incidence and Prevalence of Chronic Rhinosinusitis: A Systematic Review
7天前
已完结
[Guideline for diagnosis and treatment of chronic rhinosinusitis (2024)]
7天前
已完结
Adult chronic rhinosinusitis
7天前
已完结
Cendakimab in Adults and Adolescents with Eosinophilic Esophagitis
8天前
已完结
Mechanisms and clinical management of eosinophilic oesophagitis: an overview
8天前
已完结
Efficacy and safety of low-dose interleukin 2 in the treatment of moderate-to-severe bullous pemphigoid: A single center perspective-controlled trial
9天前
已完结
BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood
10天前
已完结
Diagnosis and treatment of bullous pemphigoid: an expert consensus statement （2025 edition）
11天前
已完结
皖公网安备34019202002308
